HES
49
-7
DE
46
8
XRAY
40
2
F
40
-2
PBI
42
-6
MOS
15
-3
SBUX
36
-3
SYF
57
-7
CNX
50
-3
FCX
39
-5
TXT
50
-3
KR
38
-7
ZTS
56
2
CCI
39
3
VZ
40
-2
SLB
39
-3
GE
65
-3
MCHP
32
-6
EQIX
57
-6
EFX
69
-5
HES
49
-7
DE
46
8
XRAY
40
2
F
40
-2
PBI
42
-6
MOS
15
-3
SBUX
36
-3
SYF
57
-7
CNX
50
-3
FCX
39
-5
TXT
50
-3
KR
38
-7
ZTS
56
2
CCI
39
3
VZ
40
-2
SLB
39
-3
GE
65
-3
MCHP
32
-6
EQIX
57
-6
EFX
69
-5
Financhill
Back

Apellis Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
37

APLS
Apellis Pharmaceuticals

Last Price:
41.02
Seasonality Move:
5.93%
Sell
15

ALNY
Alnylam Pharmaceuticals

Last Price:
246.59
Seasonality Move:
6.72%
Sell
37
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $41.05. The Score for APLS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $246.78. The Score for ALNY is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $41.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $246.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.46 Buy
Relative Strength Index (14 RSI): 60.14 Buy
Chaikin Money Flow: 854085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.92 - 39.7) Buy
Bollinger Bands (100): (36.8 - 44.46) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.98 Buy
Relative Strength Index (14 RSI): 39.94 Sell
Chaikin Money Flow: -378372 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (258.04 - 277.96) Sell
Bollinger Bands (100): (152.5 - 260.08) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.04 Buy
20-day SMA: 38.43 Buy
50-day SMA: 37.98 Buy
200-day SMA: 50.76 Sell
8-day EMA: 39.27 Buy
20-day EMA: 38.68 Buy
50-day EMA: 39.03 Buy
200-day EMA: 46.63 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 264.46 Sell
20-day SMA: 268.49 Sell
50-day SMA: 256.91 Sell
200-day SMA: 187.09 Buy
8-day EMA: 259.34 Sell
20-day EMA: 263.1 Sell
50-day EMA: 247.85 Sell
200-day EMA: 202.56 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):